{"news_desk": "Business", "print_page": "6", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ALEXANDRA STEVENSON", "person": [{"rank": 1, "role": "reported", "firstname": "Alexandra", "organization": "", "lastname": "STEVENSON"}]}, "abstract": "Pershing Square Capital Management has lost billions of dollars due to William A Ackman's bet on Valeant Pharmaceuticals International, which is putting pressure on Ackman and placing his reputation as bold moneymaker at risk.", "type_of_material": "News", "word_count": "943", "lead_paragraph": "Mr. Ackman of Pershing Square has stayed in the stock and sustained enormous losses on paper.", "pub_date": "2016-03-16T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Pressure on Valeant Puts William Ackman\u2019s Image as Moneymaker at Risk", "print_headline": "Huge Pressure on Valeant Puts Ackman\u2019s Image as a Moneymaker at Risk"}, "snippet": "Mr. Ackman of Pershing Square has stayed in the stock and sustained enormous losses on paper.", "multimedia": [{"height": 126, "url": "images/2016/03/16/business/16Ackman/16Ackman-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/03/16/business/16Ackman/16Ackman-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 399, "url": "images/2016/03/16/business/16Ackman/16Ackman-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "399", "xlarge": "images/2016/03/16/business/16Ackman/16Ackman-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/03/16/business/16Ackman/16Ackman-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/03/16/business/16Ackman/16Ackman-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/03/16/business/dealbook/pressure-on-valeant-puts-william-ackmans-image-as-moneymaker-at-risk.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Pershing Square Capital Management", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Ackman, William A", "name": "persons"}, {"rank": "4", "is_major": "N", "value": "Hedge Funds", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Stocks and Bonds", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "56e8a75b38f0d85c820e643d", "source": "The New York Times"}